BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products... Show more
BellRing Brands operates a pure-play, convenience-nutrition portfolio anchored by Premier Protein, the leading ready-to-drink (RTD) protein shake brand, and Dymatize, the top hydrolyzed protein powder brand. Its products are distributed across more than 90 countries through club, mass, food, e-commerce, specialty, drug, and convenience channels. That brand leadership and household penetration—nearly 23% for Premier Protein—provide durable structural advantages, but the category is becoming more crowded.
Competitive intensity has risen meaningfully. In recent quarters, management noted that roughly 27% of RTD category volume sold on promotion, a sharp increase from the prior year, as smaller insurgent brands invested aggressively to gain shelf space. At the same time, Premier Protein is diversifying away from a heavy reliance on the club channel, with consumption outside club growing in the high-teens range as distribution points reached an all-time high. This broader footprint reduces concentration risk but also carries near-term margin trade-offs, since single-serve formats and newer innovation start at lower margins than the core 30-gram shake.
Several developments could reshape investor sentiment over the coming quarters. First, BellRing's fiscal fourth-quarter 2026 results, typically reported in November, will offer the first read on sell-through of new products and the effectiveness of promotional actions to clear excess bottle inventory. Management guided Q4 net sales roughly flat at the midpoint, with an adjusted EBITDA margin near 10%.
Second, the fiscal 2027 pricing actions are critical. A double-digit price increase on Premier shakes, positioned in line with a competitor's earlier move, and additional Dymatize pricing are intended to offset two years of absorbed inflation and restore healthier margins. The key risk is volume elasticity, which management expects to run slightly above one-to-one.
Third, innovation launches—Premier Protein Ultimate and Sparkling Soda—target underserved, higher-growth occasions and could expand total addressable demand if they secure sustained distribution. Finally, a new chief executive officer who joined in mid-2026 and an organizational realignment expected to generate $10 million to $12 million in annualized savings, mostly in fiscal 2027, add an execution-oriented inflection point.
Analyst ratings have become notably divergent. As of mid-October 2026, the average 12-month price target sat in the low-to-mid teens, with individual targets ranging from roughly $9 to $20. Recent moves include an initiation at Buy by Exane BNP Paribas, a maintained Sell at Bank of America, and earlier downgrades from Morgan Stanley to Equal Weight. This dispersion reflects a genuine debate between valuation support and execution risk rather than a uniform consensus.
BellRing's trajectory is tightly linked to the health of the proactive-wellness category, which management expects to grow at the low end of a high-single-digit rate, largely on volume. That demand backdrop is favorable, but the company is simultaneously navigating a more value-conscious consumer: per-household RTD shake spend recently contracted for the first time in five years, shifting purchasing toward promotions and value-priced pack sizes.
On the cost side, protein and freight inflation, plus tariffs estimated at an 80-basis-point margin headwind for fiscal 2026, have been the dominant pressure points. Broader macroeconomic variables—interest rates, which affect both financing costs and consumer discretionary budgets, and commodity price swings in dairy-based proteins—will continue to influence gross margin and EBITDA (earnings before interest, taxes, depreciation, and amortization). Higher leverage, expected near four times net debt to EBITDA at fiscal year-end, also raises sensitivity to borrowing costs.
For traders seeking a data-driven view of where BRBR may head next, Tickeron's Trend Prediction Engine offers an AI-powered forecasting approach. The tool is designed to help users identify whether a stock, ETF (exchange-traded fund), or other asset may trend bullish, bearish, or sideways over the next week or month. It supports spotting developing trends, evaluating possible breakouts or reversals, and exploring predictions across a broad universe of tradable instruments, with searchable categories, historical context, and alert-oriented functionality. Explore the Trend Prediction Engine to complement your own research on BRBR.
Looking toward 2026 and beyond, the structural thesis rests on whether BellRing can convert durable category growth into more predictable, higher-margin earnings. Management has signaled that fiscal 2026 margin levels are not the "new normal" and expects improvement in fiscal 2027 through pricing, productivity, and supply-chain improvements.
Key long-term themes include market expansion into convenience and international channels, where Dymatize has posted strong distribution gains; cost-structure evolution from the organizational realignment and improved supply-and-demand planning; and margin sustainability as innovation scales past its initial lower-margin phase. Competitive threats from well-funded insurgent brands and any reversal in category penetration remain the principal risks to that path.
Capital allocation is another watch item: BellRing has historically used buybacks, but elevated leverage and a margin-recovery priority suggest near-term focus will skew toward debt reduction and reinvestment. As consensus expectations reset, the balance between restored pricing power, sustained household penetration, and disciplined cost management will likely determine how analyst ratings and price targets evolve through fiscal 2027.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that BRBR and BRCC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BRBR and BRCC's prices will move in lockstep.
| Ticker / NAME | Correlation To BRBR | 1D Price Change % | ||
|---|---|---|---|---|
| BRBR | 100% | +8.49% | ||
| BRCC - BRBR | 33% Poorly correlated | -0.20% | ||
| CENT - BRBR | 27% Poorly correlated | +4.38% | ||
| CENTA - BRBR | 27% Poorly correlated | +4.09% | ||
| SMPL - BRBR | 27% Poorly correlated | +6.58% | ||
| INGR - BRBR | 25% Poorly correlated | +0.60% | ||
More | ||||
| Ticker / NAME | Correlation To BRBR | 1D Price Change % |
|---|---|---|
| BRBR | 100% | +8.49% |
| Food: Major Diversified industry (62 stocks) | 29% Poorly correlated | -2.98% |
Industry FoodMajorDiversified
The 10-day moving average for BRBR crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 54 cases where BRBR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on BRBR as a result. In 52 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for BRBR just turned positive on October 07, 2026. Looking at past instances where BRBR's MACD turned positive, the stock continued to rise in 32 of 49 cases over the following month. The odds of a continued upward trend are 65%.
BRBR moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in 202 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 166 of 227 cases where BRBR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The 10-day RSI Indicator for BRBR moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 17 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
BRBR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.442) is normal, around the industry mean (6.720). P/E Ratio (6.860) is within average values for comparable stocks, (7.191). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. BRBR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.